RESEARCH ARTICLE Open Access A 4-week, Dose-ranging study ...
(xalatan) in the treatment of primary open-angle glaucoma and ocular hypertension Diestelhorst M, Krieglstein GK, Lusky M, Nagasubramanian S: Clinical dose-regimen studies with latanoprost, a new ocular hypotensive PGF2 alpha analogue. Surv Ophthalmol 1997, 41(Suppl 2):S77–81. ... Read Full Source
P Zer - U S Food And Drug Administration Home Page
Clinical implications, and result in significantly different safety profiles with respect to for FDA to grant first-line indications to Lumigan and Travatan on the basis of studies that Pfizer conducted on Xalatan. Thus, Pfizer requests that FDA withdraw its approval ... Read Content
Xalatan Latanoprost Ophthalmic Solution DESCRIPTION
CLINICAL STUDIES Patients with mean baseline intraocular pressure of 24 – 25 mmHg who were treated for 6 There are no adequate and well-controlled studies in pregnant women. XALATAN should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. ... Access Full Source
GENERICS IN THE PIPELINE 2012 - HealthTrans - Healthcare ...
Travatan Z® (travaoprost), and Xalatan® (latanoprost) in the prostaglandin therapeutic drug class. According to the American Academy of Ophthalmology, Clinical studies directly comparing migraine treatment options are lacking. ... View Full Source
Selective Laser Trabeculoplasty
Clinical Studies US Clinical – Initial Study United Kingdom – Prospective non-randomized case series. RCT 90o, 180o, 360o & Xalatan Canadian – RCT SLT Vs ALT Norwegian - Israeli - New US Study – RCT SLT/Meds Madhu Nagar ESCRS 2004. Selective Laser Trabeculoplasty ... Get Doc
Carbonic Anhydrase Inhibitor - Wikipedia, The Free Encyclopedia
Carbonic anhydrase inhibitors are a class of pharmaceuticals that suppress the activity of carbonic anhydrase. Their clinical use has been established as anti glaucoma agents, diuretics, antiepileptics, in the management of mountain sickness, gastric and duodenal ulcers, neurological disorders ... Read Article
MATERIAL SAFETY DATA SHEET
Trade Name: Xalatan Sterile Ophthalmic Solution Chemical Family: Mixture Intended Use: effects similar to those seen in clinical use. Long Term: Animal studies have shown a potential to cause adverse effects on the fetus. Known Clinical Effects: Nausea, abdominal discomfort, ... View This Document
Thyroid Disease: A Natural/Herbal Perspective -- Interview ...
Some studies have reported that overconsumption of soy - particularly in the form of isoflavone-packed supplements and protein powders, Clinical Herbology, Nutrition and Acupressure for the treatment of a broad range of common ailments. ... Read Article
Memorandum Sample - Department Of Health And Human Services ...
LUMIGAN® vs Xalatan® Cost-Effectiveness Model. 53. c. LUMIGAN® vs Cosopt® Cost-Effectiveness Model. 53. d. LUMIGAN® vs Travatan® Cost-Effectiveness Model. 54. 3.2. Clinical studies in a variety of settings (initial diagnosis, switch therapy, ... Fetch Here
Xalatan Assessment Report For Publication
Assessment report for Xalatan and associated names . International non-proprietary name: latanoprost . Procedure no: EMEA/H/A-29 PAE/1270 . Due to the limited duration of both pharmacokinetic and clinical studies, the long term safety profile of ... Fetch Doc
Pharmacy Benefits Management Strategic Healthcare Group
Selected studies were randomized clinical trials in patients with open-angle glaucoma or ocular hypertension and an intervention of a prostaglandin analog or timolol and a primary outcome measure of mean IOP Xalatan® 0.005%, Catalent Pharma Solns. Latanoprost Ophthalmic Solution, 0.005% ... Read Content
Warning Letter: Lumigan (bimatoprost Ophthalmic Solution)
Not been demonstrated by substantial evidence or substantial clinical experience. The studies cited, Higginbotham et al.,3 Cohen et al.,4 and Walters et al.,9 demonstrated changes in IOP that are not considered clinically significant. ... Fetch Document
Palpebral Fissure - Wikipedia, The Free Encyclopedia
In animal studies, using four times the therapeutic concentration of the ophthalmic solution Latanoprost (brand name Xalatan), the size of the palpebral fissure can be increased. The condition is reversible. Latanoprost is a prostaglandin F receptor agonist. ... Read Article
Xalatan DESCRIPTION - Error Page
CLINICAL STUDIES Patients with mean baseline intraocular pressure of 24 – 25 mmHg who were treated for 6 controlled studies in pregnant women. XALATAN should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. ... Read More
FDA Clinical Research Studies - | Trusted Lasik Surgeons, Inc.
FDA Clinical Research Studies Performed by Ophthalmology Associates Ranjan P. Malhotra, M.D.,F.A.CS. Gregg J.Berdy, M.D., F.A.CS. Robert C Brusatti, O.D.. Xalatan Given in the Evening, and Timolol Given in the Morning in Subjects With Open Angle Glaucoma ... Read Full Source
Pharmacia Xalatan DESCRIPTION - U S Food And Drug ...
CLINICAL STUDIES Patients with mean baseline intraocular pressure of 24-25 mmHg who were treated for 6 months in multi-center, randomized, are no adequate and well-controlled studies in pregnant women. XALATAN should be used during ... Read Document
PFZ XAL 08011 H 011 IOP 1O
CLINICAL STUDIES Patients with mean baseline intraocular pressure of 24 – 25 mmHg who were treated for 6 months in multi-center, randomized, controlled trials demonstrated XALATAN in clinical practice. Because they are reported voluntarily from a ... Retrieve Doc
Conjunctival Proinflammatory And Proapoptotic Effects Of ...
Clinical and experimental studies, it has been shown that long-term use of ophthalmic solutions associated with a preserva- (Xalatan; Pharmacia, Kalamazoo, MI). Timolol (BAC or BAC ) was applied twice daily, whereas latanoprost was applied once a day. ... Read More
GENERICS IN THE PIPELINE, 2011-2012 - HealthTrans ...
Xalatan® latanoprost Pfizer Glaucoma Launched 03/22/2011 Moderate Concerta® methylphenidate Ortho-McNeil ADHD 2Q 2011 (Apr) Moderate Long-term clinical studies directly comparing topical testosterone treatment options are lacking. ... Fetch Document
CIV - Error Page
CLINICAL STUDIES Anxiety Disorders XANAX Tablets were compared to placebo in double blind clinical studies (doses up to 4 mg/day) in patients with a diagnosis of anxiety or anxiety with associated depressive symptomatology. ... Access Full Source
Preservative Polyquaternium-1 Evokes Inflammation And ...
Background: In numerous clinical and experimental studies eye drop preservatives have been indicated to be detrimental on ocular epithelial cells. containing Xalatan and 0.02% BAK solution evoked total cell death signs on HCE-2 cells. ... Fetch Document
Skelaxin (Metaxalone) - The Facts Of Skelaxin (Metaxalone)
Serial liver function studies should be performed in these patients. False-positive Benedict’s tests, due to an unknown reducing substance, have been noted. CLINICAL PHARMACOLOGY: The mechanism of action of Skelaxin (metaxalone) ... Read Article
PRODUCT MONOGRAPH - Home - Pfizer.ca
In XALATAN studies of up to 24 months duration, there was no evidence of long-term drift in clinical studies comparing the intraocular-pressure reducing effect of latanoprost and timolol. Eur J Opthalmol 10 (2):95-104, 2000. 30. ... Retrieve Full Source
No comments:
Post a Comment